Dialysis specialist DaVita (NYSE: DVA) had quite the Wednesday to forget, as investors sold out of its stock following the company's latest-earnings release. On the back of news that profitability was notably lower than expected, those folks left DaVita shares with a more-than 10% decline in value on the day. This was significantly worse than the 0.3% dip of the S&P 500 index that trading session.
Revenue rose while profitability slipped
For its third quarter, DaVita earned total revenue of $3.26 billion, which was an improvement over the $3.12 billion of the same period in 2023. On the other hand, the specialty healthcare company's non-GAAP (adjusted) net income slipped over that stretch of time, declining to $222 million ($2.59 per share) from the year-ago profit of $268 million.
While DaVita's top line exceeded (if barely) the average-analyst estimate of $3.25 billion, its adjusted profitability was well below the consensus of $2.72.
Management said the slight revenue gain "was primarily due to increases in average-reimbursement rates and other normal fluctuations." It added that the usual annual-rate increases, including from the federal Medicare program, also played a part, as did a rise in hospital inpatient dialysis treatments.
Better times ahead?
DaVita also proffered selected guidance for the entirety of 2024, stating that its adjusted, per-share earnings should come in at $9.25 to $10.05, while free cash flow (FCF) is forecast to range from $950 million to $1.2 billion. Those figures for full-year 2023 were $8.47 and nearly $1.24 billion, respectively. The company did not provide an estimate for revenue.
Investors don't like pronounced earnings misses, and they punished DaVita for this one. Market players might also believe that in an environment where the U.S. population is starting to skew older, a highly specialized healthcare company should be posting more encouraging growth in its top line too.
Don’t miss this second chance at a potentially lucrative opportunity
Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this.
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:
- Amazon: if you invested $1,000 when we doubled down in 2010, you’d have $21,492!*
- Apple: if you invested $1,000 when we doubled down in 2008, you’d have $44,204!*
- Netflix: if you invested $1,000 when we doubled down in 2004, you’d have $409,559!*
Right now, we’re issuing “Double Down” alerts for three incredible companies, and there may not be another chance like this anytime soon.
*Stock Advisor returns as of October 28, 2024
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
